MNOV MediciNova, Inc. - Common Stock
NASDAQ · Biotechnology · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Ago 13, 2026
$1,78
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$1,17minimo 52 sett.
$3,90massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$88M
P/E (TTM)
-8.5
EPS (TTM)
$-0.21
Ricavi (TTM)
$920.5K
i tuoi badge
Intervallo 52 sett.
$1–$4
Rating Analisti
BUY
Prezzo Obiettivo
$8
P/E
-8.5
ROE
-25.6%
Margine di Profitto Netto
-1168.2%
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
MNOV Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$1.78
Capitalizzazione di Mercato (MRQ)
$88M
P/E (TTM)
-8.5
EPS (TTM)
$-0.21
Ricavi (TTM)
$920.5K
ROE (TTM)
-25.6%
Intervallo 52 sett.
$1–$4
MNOV Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi$409.7K2021-12-31 → 2025-12-31
EPS$-0.242021-12-31 → 2025-12-31
Flusso di cassa libero$-10M2016-12-31 → 2025-12-31
Margine netto-1168.2%2021-12-31 → 2025-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | MNOV | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E (TTM) | -8.5media 5 anni ≈-8.6 | ≈-8.6 | · | · | |
| P/S (TTM) | 95.2media 5 anni ≈87.8 | ≈87.8 | · | · | |
| P/B (MRQ) | 2.4media 5 anni ≈1.5 | ≈1.5 | 1.7 | Valore equo | |
| Prezzo / FCF (TTM) | -9.6media 5 anni ≈-9.6 | ≈-9.6 | · | · | |
| Prezzo / Flusso di cassa (TTM) | -9.6media 5 anni ≈-9.6 | ≈-9.6 | · | · | |
| Price / Tangible Book (Prezzo / Valore contabile tangibile) | 2.7media 5 anni ≈1.8 | ≈1.8 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | MNOV | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Margine Operativo (TTM) | -1287.4%media 5 anni ≈-1495.2% | ≈-1495.2% | -583.5% | Di prim'ordine | |
| Margine EBITDA (TTM) | -1285.3%media 5 anni ≈-1492.6% | ≈-1492.6% | -583.5% | Di prim'ordine | |
| Pretax Margin (Margine ante imposte) | -2927.3%media 5 anni ≈-1345.0% | ≈-1345.0% | -2927.3% | In linea | |
| Margine di Profitto Netto (TTM) | -1168.2%media 5 anni ≈-1345.6% | ≈-1345.6% | -597.4% | Di prim'ordine | |
| ROA (TTM) | -23.8%media 5 anni ≈-16.8% | ≈-16.8% | -36.6% | Di prim'ordine | |
| ROE (TTM) | -25.6%media 5 anni ≈-18.5% | ≈-18.5% | -61.0% | Di prim'ordine | |
| ROIC | -32.0%media 5 anni ≈-21.0% | ≈-21.0% | -55.9% | Di prim'ordine |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | MNOV | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 8.8media 5 anni ≈16.3 | ≈16.3 | 5.7 | Liquidità elevata | |
| Quick Ratio | 8.1media 5 anni ≈16.2 | ≈16.2 | 5.3 | Liquidità elevata |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | MNOV | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Asset Turnover (Rotazione delle attività) | 0.0media 5 anni ≈0.0 | ≈0.0 | 0.0 | Debole | |
| Revenue / Employee (Ricavi / Dipendente) | ≈$68.3K | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
38.0%
Prossimo report
Nov 11, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Ago 11, 2026 | $-0.05 | $-0.06 | 22.6% |
| 31 Marzo 2026 | Mag 14, 2026 | $-0.05 | $-0.07 | 30.0% |
| 31 Dicembre 2025 | $-0.05 | $-0.10 | 48.4% | |
| 30 Settembre 2025 | $-0.06 | $-0.10 | 41.2% | |
| 30 Giugno 2025 | $-0.07 | $-0.10 | 27.8% | |
| 31 Marzo 2025 | $-0.06 | $-0.14 | 58.0% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $409.7K | · | $1M | · | $4M | · | · | · | · | · | · | · | |
| R&D Expense | $7M | $7M | $5M | $9M | $8M | $7M | $6M | $5M | $4M | $3M | $3M | $3M | |
| SG&A Expense | $6M | $5M | $5M | $5M | $6M | $7M | $8M | $10M | $9M | $7M | $6M | $6M | |
| Operating Expenses | $14M | $13M | $11M | $15M | $14M | $14M | $14M | $16M | $13M | $11M | $9M | $9M | |
| Operating Income | $-13M | $-13M | $-10M | $-15M | $-10M | $-14M | $-14M | $-16M | $-13M | $-11M | $-9M | $-9M | |
| Interest Expense | · | · | · | · | · | · | · | · | $298 | $454 | $514 | $628 | |
| Other Non-op | $-12.8K | $-39.5K | $-502.9K | $-247.3K | $-59.5K | $-38.4K | $-46.2K | $-22.9K | $-25.6K | $-47.0K | · | · | |
| Pretax Income | $-12M | $-11M | $-9M | $-14M | $-10M | $-14M | $-13M | $-15M | $-13M | $-11M | $-9M | $-9M | |
| Income Tax | $6.0K | $5.5K | $3.0K | $2.8K | $2.6K | $-1.6K | $12.7K | $5.3K | $-2M | $3.8K | $7.4K | $-4.0K | |
| Net Income | $-12M | $-11M | $-9M | $-14M | $-10M | $-14M | $-13M | $-15M | $-11M | $-11M | $-9M | $-9M | |
| EPS (Basic) | $-0.24 | $-0.23 | $-0.17 | $-0.29 | $-0.21 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-0.24 | $-0.23 | $-0.17 | $-0.29 | $-0.21 | · | · | · | · | · | · | · | |
| Shares (Basic) | 49,063,438 | 49,046,246 | 49,046,246 | 49,045,342 | 48,596,255 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 49,063,438 | 49,046,246 | 49,046,246 | 49,045,342 | 48,596,255 | · | · | · | · | · | · | · | |
| EBITDA | $-13M | $-13M | $-10M | $-15M | $-10M | $-14M | $-14M | $-16M | $-13M | $-11M | $-9M | $-9M |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $31M | $40M | $51M | $19M | $71M | $60M | $64M | $62M | $28M | $24M | $22M | $12M | |
| Short-term Investments | · | · | · | $40M | · | · | · | · | · | · | · | · | |
| Receivables | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $184.8K | $714.5K | $174.9K | $499.4K | $578.0K | $680.2K | $511.9K | $444.9K | $336.6K | $585.8K | $649.5K | $463.5K | |
| Current Assets | $31M | $41M | $51M | $59M | $72M | $61M | $64M | $63M | $28M | $25M | $23M | $12M | |
| PP&E (Net) | $8.3K | $25.5K | $45.8K | $45.3K | $57.6K | $55.7K | $40.5K | $53.1K | $62.9K | $90.7K | $20.4K | $44.8K | |
| PP&E (Gross) | $431.1K | $428.2K | $489.3K | $478.1K | $482.8K | $579.3K | $538.4K | $536.7K | $534.6K | $590.1K | $503.7K | $506.8K | |
| Accum. Depreciation | $422.8K | $402.7K | $443.5K | $432.8K | $425.2K | $523.6K | $497.9K | $483.5K | $471.7K | $499.4K | $483.2K | $461.9K | |
| Goodwill | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | |
| Other Non-current Assets | $19.0K | $19.0K | $74.2K | $92.8K | $115.5K | $75.4K | $459.8K | $11.0K | $11.0K | · | $109.0K | $10.7K | |
| Total Assets | $46M | $56M | $66M | $74M | $87M | $75M | $79M | $77M | $43M | $40M | $38M | $27M | |
| Accounts Payable | $625.0K | $1M | $1M | $424.6K | $402.7K | $616.6K | $451.3K | $616.8K | $2M | $367.3K | $170.8K | $462.0K | |
| Accrued Liabilities | · | · | · | · | · | · | · | $2M | $1M | $1M | $1M | $1M | |
| Current Liabilities | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $3M | $2M | $1M | $2M | |
| Capital Leases | $17.1K | $211.5K | $410.7K | $523.6K | $694.7K | $2.7K | $182.6K | · | · | · | · | · | |
| Deferred Tax | $201.8K | $201.8K | $201.8K | $201.8K | $201.8K | $201.8K | $201.8K | $201.8K | $201.8K | $2M | $2M | $2M | |
| Other Non-current Liabilities | $17.1K | $211.5K | $410.7K | $523.6K | $694.7K | $2.7K | $186.4K | $27.2K | · | · | · | · | |
| Total Liabilities | $4M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | |
| Common Stock | $49.2K | $49.0K | $49.0K | $49.0K | $49.0K | $45.0K | $43.9K | $42.1K | $36.5K | $34.5K | $30.0K | $24.4K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | $365M | $352M | $333M | |
| Retained Earnings | $-439M | $-427M | $-416M | $-407M | $-393M | $-383M | $-369M | $-356M | $-341M | $-330M | $-319M | $-311M | |
| AOCI | $-127.2K | $-135.2K | $-118.1K | $-115.3K | $-98.9K | $-88.2K | $-92.7K | $-93.2K | $-94.6K | $-96.0K | $-102.8K | $-101.0K | |
| Stockholders' Equity | $42M | $53M | $62M | $70M | $84M | $71M | $75M | $73M | $39M | $35M | $33M | $22M | |
| Liabilities + Equity | $46M | $56M | $66M | $74M | $87M | $75M | $79M | $77M | $43M | $40M | $38M | $27M | |
| Shares Outstanding | 49,221,246 | 49,046,246 | 49,046,246 | 49,046,246 | 49,043,246 | 45,024,560 | 43,908,065 | 42,081,306 | 36,452,893 | 34,523,678 | 29,956,495 | 24,436,317 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $20.1K | $21.1K | $20.3K | $17.7K | $26.1K | $21.3K | $23.9K | $25.9K | $28.1K | $14.1K | $26.7K | $40.2K | |
| Stock-based Comp | $829.1K | $1M | $710.7K | $642.5K | $2M | $3M | $4M | $6M | $4M | $4M | $2M | $2M | |
| Deferred Tax | · | · | · | · | · | · | · | · | $-2M | · | · | $0 | |
| Other Non-cash | $1M | $-806.2K | $409.5K | $497.3K | $-991.0K | $-169.4K | $-319.9K | $-795.2K | $1M | $333.1K | $-359.5K | $8M | |
| Operating Cash Flow | $-10M | $-11M | $-7M | $-13M | $-9M | $-11M | $-9M | $-9M | $-7M | $-7M | $-7M | $816.5K | |
| CapEx | $2.9K | $895 | $21.3K | $5.0K | $28.7K | $36.5K | $11.3K | $10.2K | · | $84.5K | $2.3K | $3.5K | |
| Investing Cash Flow | $-2.9K | $-697 | $40M | $-40M | $-28.7K | $-36.5K | $-11.3K | $626.3K | · | $-84.5K | · | · | |
| Stock Issued | $244.0K | $0 | · | · | · | · | · | · | · | · | $17M | $4M | |
| Net Stock Activity | $244.0K | · | · | · | · | · | · | · | · | · | $17M | · | |
| Financing Cash Flow | $244.0K | $0 | · | $7.9K | $21M | $7M | $11M | $43M | $11M | $9M | · | · | |
| Net Change in Cash | $-10M | $-11M | $32M | $-53M | $11M | $-4M | $1M | $34M | $4M | $2M | $10M | $5M | |
| Taxes Paid | $6.0K | $5.0K | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-10M | $-11M | $-7M | $-13M | $-9M | $-11M | $-9M | $-9M | · | $-7M | $-7M | $813.0K | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-7M | $-7M | $812.4K |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -3242.5% | · | -990.0% | · | -253.0% | · | · | · | · | · | · | · | |
| Net Margin | -2928.8% | · | -857.2% | · | -251.0% | · | · | · | · | · | · | · | |
| Pretax Margin | -2927.3% | · | -856.9% | · | -250.9% | · | · | · | · | · | · | · | |
| EBITDA Margin | -3237.6% | · | -988.0% | · | -252.4% | · | · | · | · | · | · | · | |
| ROA | -23.6% | -18.1% | -12.2% | -17.4% | -12.4% | -17.9% | -16.6% | -24.3% | -26.8% | -28.0% | -27.1% | -32.4% | |
| ROE | -27.1% | -20.5% | -13.5% | -19.6% | -11.9% | -19.1% | -17.3% | -20.0% | -30.5% | -32.3% | -32.3% | -38.8% | |
| ROIC | -32.0% | -24.1% | -15.9% | -20.8% | -12.2% | -19.9% | -18.8% | -21.3% | -29.2% | -31.5% | -27.0% | -41.9% |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.2 | 13.9 | 15.6 | 18.5 | 25.4 | 27.7 | 28.9 | 28.6 | 9.8 | 15.2 | 15.2 | 7.6 | |
| Quick Ratio | 8.1 | 13.6 | 15.6 | 18.3 | 25.2 | 27.4 | 28.6 | 28.4 | 9.7 | 14.8 | 14.8 | 7.3 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -43715.1 | -23968.8 | -17164.2 | -14686.3 |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | · | 0.0 | · | · | · | · | · | · | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.84 | $1.07 | $1.27 | $1.43 | $1.71 | $1.58 | $1.71 | $1.74 | $1.06 | $1.00 | $1.09 | $0.90 | |
| Revenue / Share | $0.01 | · | $0.02 | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-0.20 | $-0.22 | $-0.15 | $-0.26 | · | · | · | · | · | · | · | · | |
| Cash / Share | $0.63 | $0.82 | $1.04 | $0.38 | $1.46 | $1.33 | $1.45 | $1.48 | $0.77 | $0.70 | $0.74 | $0.48 | |
| EPS (TTM) | $-0.24 | $-0.23 | $-0.17 | $-0.29 | $-0.21 | $-0.24 | $-0.24 | $-0.24 | $-0.24 | $-0.24 | $-0.24 | $-0.24 |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $409.7K | · | $1M | · | $4M | · | · | · | · | · | · | · | |
| Net Income TTM | $-12M | $-11M | $-9M | $-14M | $-10M | $-14M | $-13M | $-15M | $-11M | $-11M | $-9M | $-9M | |
| Market Cap | $64M | $103M | $74M | $101M | $131M | $237M | $296M | $344M | $236M | $208M | $106M | $74M | |
| P/E | -5.5 | -9.1 | -8.8 | -7.1 | -12.8 | -21.9 | -28.1 | -34.0 | -27.0 | -25.1 | -14.8 | -12.7 | |
| P/S | 157.4 | · | 73.6 | · | 32.6 | · | · | · | · | · | · | · | |
| P/B | 1.6 | 2.0 | 1.2 | 1.4 | 1.6 | 3.3 | 4.0 | 4.7 | 6.1 | 6.0 | 3.2 | 3.4 | |
| P / Tangible Book | 2.0 | 2.4 | 1.4 | 1.7 | 1.8 | 3.8 | · | · | · | · | · | · | |
| P / Cash Flow | -6.6 | -9.7 | -9.9 | -7.8 | -14.0 | -21.9 | -32.4 | -37.7 | -34.1 | -31.8 | -14.9 | 91.0 | |
| P / FCF | -6.6 | -9.7 | -9.9 | -7.8 | -14.0 | -21.8 | -32.4 | -37.7 | · | -31.4 | -14.9 | 91.4 | |
| Earnings Yield | -18.3% | -10.9% | -11.3% | -14.1% | -7.8% | -4.6% | -3.6% | -2.9% | -3.7% | -4.0% | -6.8% | -7.9% |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $458.4K | $187.0K | $151.7K | $123.3K | $134.6K | · | · | · | · | · | $0 | $1M | · | · | · | · | |
| R&D Expense | $900.0K | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $700.0K | $2M | $1M | $2M | $2M | |
| SG&A Expense | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $839.3K | $1M | $2M | $1M | $1M | $1M | |
| Operating Expenses | $3M | $3M | $3M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $3M | $3M | $3M | $4M | |
| Operating Income | $-3M | $-3M | $-3M | $-3M | $-4M | $-3M | $-3M | $-3M | $-3M | $-3M | $-2M | $-1M | $-3M | $-3M | $-3M | $-4M | |
| Other Non-op | $-4.9K | $-3.4K | $-5.8K | $-10.2K | $952 | $2.3K | $-15.5K | $9.1K | $-17.1K | $-16.0K | $-2.2K | $-14.2K | $-23.2K | $-463.3K | $-194.7K | $-8.5K | |
| Net Income | $-2M | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | $-2M | $-723.1K | $-3M | $-3M | $-3M | $-4M | |
| EPS (Basic) | $-0.05 | $-0.05 | $-0.05 | $-0.06 | $-0.07 | $-0.06 | $-0.06 | $-0.06 | $-0.05 | $-0.06 | $-0.04 | $-0.01 | $-0.06 | $-0.06 | $-0.07 | $-0.07 | |
| EPS (Diluted) | $-0.05 | $-0.05 | $-0.05 | $-0.06 | $-0.07 | $-0.06 | $-0.06 | $-0.06 | $-0.05 | $-0.06 | $-0.04 | $-0.01 | $-0.06 | $-0.06 | $-0.07 | $-0.07 | |
| Shares (Basic) | 49,221,246 | 49,221,246 | · | 49,046,246 | 49,046,246 | 49,046,246 | · | 49,046,246 | 49,046,246 | 49,046,246 | · | 49,046,246 | 49,046,246 | 49,046,246 | · | 49,046,246 | |
| Shares (Diluted) | 49,221,246 | 49,221,246 | · | 49,046,246 | 49,046,246 | 49,046,246 | · | 49,046,246 | 49,046,246 | 49,046,246 | · | 49,046,246 | 49,046,246 | 49,046,246 | · | 49,046,246 | |
| EBITDA | $-3M | $-3M | · | $-3M | $-4M | $-3M | · | $-3M | $-3M | $-3M | · | $-1M | $-3M | $-3M | · | $-4M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $25M | $27M | $31M | $33M | $34M | $37M | $40M | $42M | $44M | $47M | $51M | $52M | $53M | $55M | $19M | $53M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $40M | · | |
| Receivables | $0 | $245.1K | · | $0 | $134.6K | · | · | · | · | · | · | $1M | · | · | · | · | |
| Prepaid Expense | $505.5K | $571.5K | $184.8K | $359.9K | $729.6K | $1M | $714.5K | $984.9K | $1M | $724.8K | $174.9K | $488.8K | $645.5K | $775.0K | $499.4K | $641.7K | |
| Current Assets | $26M | $28M | $31M | $33M | $35M | $38M | $41M | $43M | $46M | $48M | $51M | $53M | $54M | $56M | $59M | $53M | |
| PP&E (Net) | $9.8K | $14.9K | $8.3K | $12.9K | $15.4K | $20.4K | $25.5K | $30.8K | $35.8K | $40.4K | $45.8K | $51.2K | $54.6K | $41.1K | $45.3K | $45.9K | |
| PP&E (Gross) | · | · | $431.1K | · | · | · | $428.2K | · | · | · | $489.3K | · | · | · | $478.1K | · | |
| Accum. Depreciation | · | · | $422.8K | · | · | · | $402.7K | · | · | · | $443.5K | · | · | · | $432.8K | · | |
| Goodwill | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | |
| Other Non-current Assets | $0 | $0 | $19.0K | $19.0K | $19.0K | $19.0K | $19.0K | $19.0K | $19.0K | $70.4K | $74.2K | $71.1K | $72.8K | $77.5K | $92.8K | $101.7K | |
| Total Assets | $40M | $43M | $46M | $48M | $50M | $52M | $56M | $58M | $60M | $63M | $66M | $68M | $69M | $71M | $74M | $78M | |
| Accounts Payable | $950.5K | $852.4K | $625.0K | $746.0K | $569.4K | $718.9K | $1M | $708.2K | $667.7K | $804.8K | $1M | $736.9K | $548.2K | $585.1K | $424.6K | $552.7K | |
| Current Liabilities | $3M | $3M | $4M | $3M | $3M | $2M | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $5M | |
| Capital Leases | $0 | $0 | $17.1K | $74.4K | $117.0K | $165.2K | $211.5K | $255.2K | $302.5K | $351.2K | $410.7K | $463.8K | $519.7K | $489.4K | $523.6K | $555.8K | |
| Deferred Tax | $201.8K | $201.8K | $201.8K | $201.8K | $201.8K | $201.8K | $201.8K | $201.8K | $201.8K | $201.8K | $201.8K | $201.8K | $201.8K | $201.8K | $201.8K | $201.8K | |
| Other Non-current Liabilities | $0 | $0 | $17.1K | $74.4K | $117.0K | $165.2K | $211.5K | $255.2K | $302.5K | $351.2K | $410.7K | $463.8K | $519.7K | $489.4K | $523.6K | $555.8K | |
| Total Liabilities | $3M | $3M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $3M | $4M | $3M | $4M | $5M | |
| Common Stock | $49.2K | $49.2K | $49.2K | $49.0K | $49.0K | $49.0K | $49.0K | $49.0K | $49.0K | $49.0K | $49.0K | $49.0K | $49.0K | $49.0K | $49.0K | $49.0K | |
| Retained Earnings | $-444M | $-441M | $-439M | $-436M | $-433M | $-430M | $-427M | $-424M | $-421M | $-418M | $-416M | $-414M | $-413M | $-410M | $-407M | $-404M | |
| AOCI | $-127.4K | $-128.1K | $-127.2K | $-126.8K | $-127.4K | $-130.1K | $-135.2K | $-123.8K | $-131.5K | $-127.0K | $-118.1K | $-123.8K | $-121.0K | $-116.8K | $-115.3K | $-124.3K | |
| Stockholders' Equity | $37M | $39M | $42M | $44M | $47M | $50M | $53M | $55M | $57M | $60M | $62M | $65M | $65M | $68M | $70M | $73M | |
| Liabilities + Equity | $40M | $43M | $46M | $48M | $50M | $52M | $56M | $58M | $60M | $63M | $66M | $68M | $69M | $71M | $74M | $78M | |
| Shares Outstanding | 49,221,246 | 49,221,246 | 49,221,246 | 49,046,246 | 49,046,246 | 49,046,246 | 49,046,246 | 49,046,246 | 49,046,246 | 49,046,246 | 49,046,246 | 49,046,246 | 49,046,246 | 49,046,246 | 49,046,246 | 49,046,246 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $5.0K | $4.3K | $4.6K | $5.3K | $5.1K | $5.2K | $5.2K | $5.2K | $5.4K | $5.3K | $5.5K | $5.7K | $5.0K | $4.1K | $4.3K | $4.5K | |
| Stock-based Comp | $176.8K | $407.8K | $180.6K | $157.7K | $204.9K | $285.9K | $264.0K | $504.9K | $207.5K | $215.4K | $-237.4K | $219.1K | $325.7K | $403.3K | $128.7K | $158.3K | |
| Other Non-cash | · | $-1M | · | · | · | $-1M | · | · | · | $-1M | · | · | · | $-667.3K | · | · | |
| Operating Cash Flow | $-2M | $-3M | $-2M | $-2M | $-2M | $-4M | $-2M | $-2M | $-3M | $-4M | $-499.1K | $-1M | $-2M | $-3M | $-4M | $-3M | |
| CapEx | $0 | $10.8K | $0 | $2.9K | $0 | $0 | $-2 | $6 | · | · | $-22 | $2.7K | · | · | · | · | |
| Investing Cash Flow | $0 | $-10.8K | $0 | $-2.9K | $0 | $0 | $1 | $193 | · | · | $22 | $-2.7K | $-18.6K | $40M | $-30M | · | |
| Financing Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Net Change in Cash | $-2M | $-3M | $-2M | $-2M | $-2M | $-4M | $-2M | $-2M | $-3M | $-4M | $-507.9K | $-1M | $-2M | $37M | $-34M | $-13M | |
| Free Cash Flow | · | $-3M | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -554.3% | -1516.6% | · | -2741.7% | -2679.9% | · | · | · | · | · | · | -114.7% | · | · | · | · | |
| Net Margin | -504.8% | -1383.1% | · | -2473.6% | -2437.8% | · | · | · | · | · | · | -72.3% | · | · | · | · | |
| EBITDA Margin | -554.3% | -1514.3% | · | -2741.7% | -2679.9% | · | · | · | · | · | · | -114.7% | · | · | · | · | |
| ROA | -5.1% | -5.4% | · | -5.8% | -5.9% | -5.0% | · | -4.5% | -3.7% | -4.2% | · | -0.99% | · | -3.8% | · | -4.3% | |
| ROE | -5.5% | -5.8% | · | -6.2% | -6.3% | -5.2% | · | -4.8% | -3.9% | -4.4% | · | -1.1% | · | -3.9% | · | -4.6% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.8 | 9.1 | · | 9.9 | 13.3 | 17.7 | · | 16.7 | 18.2 | 19.1 | · | 18.9 | · | 20.6 | · | 11.7 | |
| Quick Ratio | 8.6 | 8.9 | · | 9.8 | 13.0 | 17.1 | · | 16.3 | 17.8 | 18.8 | · | 18.7 | · | 20.4 | · | 11.6 |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | · | · | · | 0.0 | · | · | · | · | |
| Receivables Turnover | 6.8 | 0.1 | · | 0.2 | 2.0 | · | · | · | · | · | · | 2.0 | · | · | · | · |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.76 | $0.80 | · | $0.90 | $0.96 | $1.02 | · | $1.12 | $1.17 | $1.22 | · | $1.32 | · | $1.38 | · | $1.49 | |
| Revenue / Share | $0.01 | $0.00 | · | $0.00 | $0.00 | · | · | · | · | · | · | $0.02 | · | · | · | · | |
| Cash Flow / Share | · | $-0.07 | · | · | · | $-0.08 | · | · | · | $-0.08 | · | · | · | $-0.06 | · | · | |
| Cash / Share | $0.52 | $0.56 | · | $0.66 | $0.70 | $0.75 | · | $0.86 | $0.90 | $0.96 | · | $1.05 | · | $1.13 | · | $1.07 | |
| EPS (TTM) | $-0.21 | $-0.23 | · | $-0.25 | $-0.25 | $-0.23 | · | $-0.21 | $-0.16 | $-0.17 | · | $-0.20 | $-0.26 | $-0.28 | · | $-0.26 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $920.5K | $596.6K | · | · | · | · | · | · | · | · | · | · | $4M | $4M | · | $4M | |
| Net Income TTM | $-11M | $-12M | · | $-12M | $-12M | $-11M | · | $-10M | $-8M | $-8M | · | $-10M | $-12M | $-14M | · | $-13M | |
| Market Cap | $65M | $67M | · | $62M | $64M | $72M | · | $103M | $71M | $71M | · | $103M | · | $106M | · | $106M | |
| P/E | -6.3 | -6.0 | · | -5.1 | -5.2 | -6.3 | · | -10.0 | -9.0 | -8.5 | · | -10.4 | -8.8 | -7.7 | · | -8.3 | |
| P/S | 70.6 | 113.0 | · | · | · | · | · | · | · | · | · | · | 27.9 | 26.2 | · | 26.4 | |
| P/B | 1.7 | 1.7 | · | 1.4 | 1.4 | 1.4 | · | 1.9 | 1.2 | 1.2 | · | 1.6 | · | 1.6 | · | 1.5 | |
| P / Tangible Book | 2.3 | 2.3 | · | 1.8 | 1.7 | 1.8 | · | 2.3 | 1.5 | 1.4 | · | 1.9 | · | 1.8 | · | 1.7 | |
| P / Cash Flow | · | -19.4 | · | · | · | -18.9 | · | · | · | -18.4 | · | · | · | -33.3 | · | · | |
| Earnings Yield | -15.9% | -16.8% | · | -19.7% | -19.1% | -15.8% | · | -10.0% | -11.1% | -11.7% | · | -9.6% | -11.3% | -13.0% | · | -12.0% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ricavi | $409.7K | · | $1M | · | $4M |
| Margine Operativo % | -3242.5% | · | -990.0% | · | -253.0% |
| Utile netto | $-12M | $-11M | $-9M | $-14M | $-10M |
| EPS Diluito | $-0.24 | $-0.23 | $-0.17 | $-0.29 | $-0.21 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rapporto corrente | 8.2 | 13.9 | 15.6 | 18.5 | 25.4 |
| Quick Ratio | 8.1 | 13.6 | 15.6 | 18.3 | 25.2 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-10M | $-11M | $-7M | $-13M | $-9M |
Proprietari istituzionali (13F) 31 filer · $7.8M totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
31
Valore detenuto
$7.8M
Nuove posizioni
3
Posizioni chiuse
4
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 3 (-2 vs trimestre precedente) | 4 (-1 vs trimestre precedente) | 5 (-3 vs trimestre precedente) | 8 (-1 vs trimestre precedente) | -226K |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| Essex Woodlands Management, Inc. | $1.459.842 | 1.105.941 | 18,78% | Azioni |
| BlackRock, Inc. | $992.760 | 752.091 | 12,77% | Azioni |
| VANGUARD GROUP INC | $924.369 | 705.625 | 11,89% | Azioni |
| CITIGROUP INC | $839.144 | 635.715 | 10,80% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $803.949 | 609.052 | 10,34% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $712.087 | 539.312 | 9,16% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $373.043 | 282.608 | 4,80% | Azioni |
| UBS Group AG | $293.304 | 222.200 | 3,77% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $271.128 | 205.400 | 3,49% | Azioni |
| STATE STREET CORP | $255.681 | 193.698 | 3,29% | Azioni |
| NORTHERN TRUST CORP | $189.638 | 143.665 | 2,44% | Azioni |
| Bank of New York Mellon Corp | $103.325 | 78.277 | 1,33% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $94.388 | 71.506 | 1,21% | Azioni |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $73.961 | 56.031 | 0,95% | Azioni |
| SBI Securities Co., Ltd. | $67.952 | 51.479 | 0,87% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $66.728 | 50.552 | 0,86% | Azioni |
| BARCLAYS PLC | $56.504 | 42.806 | 0,73% | Azioni |
| Schonfeld Strategic Advisors LLC | $47.726 | 36.157 | 0,61% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $35.313 | 26.752 | 0,45% | Azioni |
| JANE STREET GROUP, LLC | $20.880 | 15.818 | 0,27% | Azioni |
| Vanguard Global Advisers, LLC | $20.591 | 15.599 | 0,26% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $17.854 | 13.526 | 0,23% | Azioni |
| TWO SIGMA ADVISERS, LP | $17.685 | 13.500 | 0,23% | Azioni |
| BANK OF AMERICA CORP /DE/ | $17.370 | 13.159 | 0,22% | Azioni |
| Focus Partners Advisor Solutions, LLC | $13.200 | 10.000 | 0,17% | Azioni |
| MORGAN STANLEY | $2.640 | 2.000 | 0,03% | Azioni |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $403 | 305 | 0,01% | Azioni |
| OSAIC HOLDINGS, INC. | $87 | 66 | 0,00% | Azioni |
| Larson Financial Group LLC | $7 | 5 | 0,00% | Azioni |
| HANTZ FINANCIAL SERVICES, INC. | $6 | 4.232 | 0,00% | Azioni |
| Caitong International Asset Management Co., Ltd | $3 | 2 | 0,00% | Azioni |
Attivisti e proprietari del 5%+ 4 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| 3D Investment Partners Pte. Ltd., 3D Opportunity Master Fund ×3 depositi | 29 Settembre 2026 | 9,90% | Modifica | · | SEC |
| KISSEI PHARMACEUTICAL CO., LTD ×3 depositi | 14 Giugno 2017 | · | Deposito iniziale | Investimento passivo | SEC |
| Essex Woodlands Health Ventures Fund VI, L.P., Essex Woodlands Health Ventures VI, L.P., Essex Woodlands Health Ventures VI, L.L.C., James L. Currie, Martin P. Sutter, Immanuel Thangaraj, Jeff Himawan, Ph.D, Petri Vainio, MD, Ph.D. ×2 depositi | 12 Febbraio 2016 | · | Deposito iniziale | · | SEC |
| Yuichi Iwaki | 28 Gennaio 2011 | · | Deposito iniziale | Investimento passivo | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 27 insider · 13 dirigenti · 12 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Yuichi Iwaki | President and CEO | 16 Gennaio 2026 A | 966.933 | 0 | 0 | $0 |
| Esther Van Den Boom | Chief Financial Officer | 07 Agosto 2014 A | · | 0 | 0 | $0 |
| Shintaro Asako | Chief Financial Officer | 29 Gennaio 2010 A | · | 0 | 0 | $0 |
| Kazuko Matsuda | Chief Medical Officer | 16 Gennaio 2026 A | 322.996 | 0 | 0 | $0 |
| Geoffrey Obrien | Vice President | 09 Gennaio 2024 A | 48.318 | 0 | 0 | $0 |
| Federico C.A. Gaeta | Chief Scientific Officer | 22 Aprile 2021 A | · | 0 | 0 | $0 |
| Masatsune Okajima | VP and Head of Japanese Office | 28 Febbraio 2019 M | 1.040.530 | 0 | 0 | $0 |
| Michael Denis Coffee | Chief Business Officer | 13 Maggio 2013 A | 4.000 | 0 | 0 | $0 |
| Kirk William Johnson | Chief Scientific Officer | 13 Maggio 2013 A | 1.700 | 0 | 0 | $0 |
| Michael E Kalafer | Chief Medical Officer | 28 Luglio 2009 X | 31.744 | 0 | 0 | $0 |
| Richard E Gammans SR | Chief Development Officer | 30 Gennaio 2009 A | · | 0 | 0 | $0 |
| Kenneth W Locke | Chief Scientific Officer | 07 Gennaio 2008 A | · | 0 | 0 | $0 |
| Joji Suzuji | Sr. V.P., Finance & Admin. | 04 Gennaio 2006 A | · | 0 | 0 | $0 |
| Nicole Lemerond | Direttore | 23 Giugno 2026 A | · | 0 | 0 | $0 |
| Carolyn Beaver | Direttore | 23 Giugno 2026 A | · | 0 | 0 | $0 |
| Hideki Nagao | Direttore | 23 Giugno 2026 A | 0 | 0 | 0 | $0 |
| Yutaka Kobayashi | Direttore | 16 Giugno 2020 A | 25.000 | 0 | 0 | $0 |
| Yoshio Ishizaka | Direttore | 10 Giugno 2019 A | 10.000 | 0 | 0 | $0 |
| Tatsuo Izumi | Direttore | 12 Dicembre 2013 S | 600.000 | 0 | 0 | $0 |
| Arlene Morris | Direttore | 21 Maggio 2013 M | 0 | 0 | 0 | $0 |
| David D O'Toole | Direttore | 29 Maggio 2012 P | 5.000 | 0 | 0 | $0 |
| Hiroaki Shigeta | Direttore | 10 Maggio 2012 M | 45.000 | 0 | 0 | $0 |
| John K A Prendergast | Direttore | 18 Luglio 2011 A | · | 0 | 0 | $0 |
| Jeff Himawan | Direttore | 14 Giugno 2011 A | · | 0 | 0 | $0 |
| Alan W Dunton | Direttore | 11 Giugno 2010 A | · | 0 | 0 | $0 |
| Daniel Vapnek | · | 09 Giugno 2008 A | · | 0 | 0 | $0 |
| Tanabe Holding America Inc. | · | 13 Ottobre 2006 D | 5.000.000 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 2 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
MNOV Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 9 analisti
COMPRA
Target mediano
$8.00
+349,4%
2 22,2%
Acquisto forte
6 66,7%
Compra
1 11,1%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
4 analisti · 2026-09-27Target medio $8.25 +363,5%
← Sotto tutti i target
Prezzo attuale $1.78
Basso$6.00
Media$8.25
Alto$11.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| MNOV | $64M | -5.5 | · | -2928.8% | -27.1% | · |
| ATRA | $132M | 7.0 | -6.3% | 27.1% | -88.9% | · |
| BMEA | $90M | -1.1 | -67.1% | -3326.0% | -216.6% | · |
| RLYB | $4M | -0.4 | 34.9% | -1046.4% | -17.3% | · |
| ICCC | · | -51.2 | 4.3% | · | · | · |
| CTOR | $170M | -6.0 | · | · | -61.5% | · |
| CNXU | · | · | · | · | · | · |
| EQ | $95M | -4.0 | 13.9% | · | -133.1% | · |
| CRDF | $192M | -4.1 | -13.2% | -7732.0% | -88.2% | · |
| ACRV | $76M | -1.2 | · | · | -61.0% | · |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 13, 2026